These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3358362)

  • 21. Disposition and tumour concentrations of platinum in hypoalbuminaemic patients after treatment with cisplatin for cancer of the head and neck.
    Holding JD; Lindup WE; Bowdler DA; Siodlak MZ; Stell PM
    Br J Clin Pharmacol; 1991 Aug; 32(2):173-9. PubMed ID: 1931468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of whole body hyperthermia effect on cisplatin distribution in spontaneous canine tumors.
    Page RL; Lee J; Riviere JE; Dodge RK; Thrall DE; Dewhirst MW
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1097-102. PubMed ID: 7607930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver and tumor uptake and plasma pharmacokinetic of arterial cisplatin administered with and without starch microspheres in patients with liver metastases.
    Civalleri D; Esposito M; Fulco RA; Vannozzi M; Balletto N; De Cian F; Percivale PL; Merlo F
    Cancer; 1991 Sep; 68(5):988-94. PubMed ID: 1913493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transplacental passage of Pt after treatment with the new triamine complex cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N4]-chloride platinum (II) monohydrochloride monohydrate.
    Ognio E; Chiavarina B; Caviglioli G; Lapide M; Viale M
    Arch Toxicol; 2004 Oct; 78(10):584-8. PubMed ID: 15150682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platinum drug-DNA interactions in human tissues measured by cisplatin-DNA enzyme-linked immunosorbent assay and atomic absorbance spectroscopy.
    Poirier MC; Reed E; Shamkhani H; Tarone RE; Gupta-Burt S
    Environ Health Perspect; 1993 Mar; 99():149-54. PubMed ID: 8319613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population pharmacokinetic analysis of cisplatin and its metabolites in cancer patients: possible misinterpretation of covariates for pharmacokinetic parameters calculated from the concentrations of unchanged cisplatin, ultrafiltered platinum and total platinum.
    Hanada K; Nishijima K; Ogata H; Atagi S; Kawahara M
    Jpn J Clin Oncol; 2001 May; 31(5):179-84. PubMed ID: 11450990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uptake and retention of platinum in patients undergoing cisplatin therapy.
    Jonson R; Börjesson J; Mattsson S; Unsgaard B; Wallgren A
    Acta Oncol; 1991; 30(3):315-9. PubMed ID: 2036240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical pharmacology of intraperitoneal cisplatin.
    Lopez JA; Krikorian JG; Reich SD; Smyth RD; Lee FH; Issell BF
    Gynecol Oncol; 1985 Jan; 20(1):1-9. PubMed ID: 4038390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of adjuvant hyaluronidase in tumors refractory to chemotherapy. Review of the literature and pharmacokinetics of cisplatin after regional administration in animals and humans].
    Civalleri D; Esposito M; De Cian F; Balletto N; Vannozzi MO; Mondini G; Carrabetta S; Bocchio MM
    G Chir; 1997 Apr; 18(4):175-81. PubMed ID: 9303630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid determination of platinum by flameless atomic absorption spectrophotometry following the administration of cisplatin to cancer patients.
    el-Yazigi A; Al-Saleh I
    Ther Drug Monit; 1986; 8(3):318-20. PubMed ID: 3750375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intratumoural administration of cisplatin in slow-release devices: II. Pharmacokinetics and intratumoural distribution.
    Deurloo MJ; Kop W; van Tellingen O; Bartelink H; Begg AC
    Cancer Chemother Pharmacol; 1991; 27(5):347-53. PubMed ID: 1998994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of platinum in human gynecologic tissues and pelvic lymph nodes after administration of cisplatin.
    Tokuhashi Y; Kikkawa F; Ishikawa H; Tamakoshi K; Hattori S; Matsuzawa K; Inoue T; Suganuma N; Tomoda Y
    Gynecol Obstet Invest; 1997; 44(4):270-4. PubMed ID: 9415527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noninvasive monitoring of drug biodistribution and metabolism: studies with intraarterial Pt-195m-cisplatin in humans.
    Shani J; Bertram J; Russell C; Dahalan R; Chen DC; Parti R; Ahmadi J; Kempf RA; Kawada TK; Muggia FM
    Cancer Res; 1989 Apr; 49(7):1877-81. PubMed ID: 2924326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue distribution of cis-diamminedichloroplatinum(II) following intraperitoneal administration to patients with recurrent gastric cancer.
    Kusumoto T; Maehara Y; Sakaguchi Y; Kakeji Y; Nohzuka T; Furusawa M; Sugimachi K
    Oncology; 1993; 50(4):214-7. PubMed ID: 8497372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
    Bonetti A; Apostoli P; Zaninelli M; Pavanel F; Colombatti M; Cetto GL; Franceschi T; Sperotto L; Leone R
    Clin Cancer Res; 1996 Nov; 2(11):1829-35. PubMed ID: 9816137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gamma camera imaging of platinum in tumours and tissues of patients after administration of 191Pt-cisplatin.
    Areberg J; Björkman S; Einarsson L; Frankenberg B; Lundqvist H; Mattsson S; Norrgren K; Scheike O; Wallin R
    Acta Oncol; 1999; 38(2):221-8. PubMed ID: 10227445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platinum accumulation in the kidney and changes in creatinine clearance following chemotherapy with cisplatin in humans.
    Uozumi J; Ueda T; Yasumasu T; Koikawa Y; Naito S; Kumazawa J; Kamura T; Nakano H; Sueishi K
    Urol Int; 1993; 51(2):57-61. PubMed ID: 8351755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin.
    Meerum Terwogt JM; Groenewegen G; Pluim D; Maliepaard M; Tibben MM; Huisman A; ten Bokkel Huinink WW; Schot M; Welbank H; Voest EE; Beijnen JH; Schellens JM
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):201-10. PubMed ID: 11935212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma pharmacokinetics and tissue and brain distribution of cisplatin in musk shrews.
    Eiseman JL; Beumer JH; Rigatti LH; Strychor S; Meyers K; Dienel S; Horn CC
    Cancer Chemother Pharmacol; 2015 Jan; 75(1):143-52. PubMed ID: 25398697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetics of tissue disposition of cis-ammine/cyclohexylamine-dichloroplatinum(II) and cisplatin in mice bearing FSaIIC tumors.
    Yoshida M; Khokhar AR; Zhang YP; Thai G; Siddik ZH
    Cancer Chemother Pharmacol; 1994; 35(1):38-44. PubMed ID: 7987975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.